Press "Enter" to skip to content

Tag: United States

Novavax says its COVID-19 shot is on track for full FDA approval after delay

WASHINGTON (AP) — Novavax’s closely watched COVID-19 vaccine is on track for full approval after additional discussions with the Food and Drug Administration, the company said Wednesday.

The news sent company shares soaring more than 21% in morning trading and appeared to resolve concerns that Trump administration officials might be holding up a decision on the shot.

Comments closed

RFK Jr. eyes reversing CDC’s Covid-19 vaccine recommendation for children

HHS Secretary Robert F. Kennedy Jr. is weighing pulling the Covid-19 vaccine from the government’s list of recommended immunizations for children, two people familiar with the discussions told POLITICO.

The directive under consideration would remove the Covid shot from the childhood vaccine schedule maintained by the Centers for Disease Control and Prevention and widely used by physicians to guide vaccine distribution, marking Kennedy’s most significant move yet to shake up the nation’s vaccination practices.

Comments closed

Federal cuts threaten to close Pennsylvania lab that certifies N95s and other respirators in June

The Pennsylvania laboratory that certifies all of the country’s NIOSH-approved respirators is on the chopping block. HHS is stonewalling employees who raise questions.

Comments closed

Internal budget document reveals extent of Trump’s proposed health cuts

The Trump administration is seeking to deeply slash budgets for federal health programs, a roughly one-third cut in discretionary spending by the Department of Health and Human Services, according to a preliminary budget document obtained by The Washington Post.

The HHS budget draft, known as a “passback,” offers the first full look at the health and social service priorities of President Donald Trump’s Office of Management and Budget as it prepares to send his 2026 fiscal year budget request to Congress. It shows how the Trump administration plans to reshape the federal health agencies that oversee food and drug safety, manage the nation’s response to infectious-disease threats and drive biomedical research.

Comments closed

Health secretary RFK Jr. declares certain vaccines have ‘never worked,’ flummoxing scientists

Health secretary Robert F. Kennedy Jr. has expressed another unorthodox view on vaccines, with the long-time vaccine critic declaring that vaccines for respiratory bugs that target a sole part of the pathogen they are meant to protect against do not work.

The claim was dismissed as erroneous by vaccine experts, who were befuddled by the secretary’s theory, espoused during an interview with CBS News.

Kennedy made the claim in explaining a controversial recent decision by political appointees at the Food and Drug Administration to delay granting a full license to Novavax’s Covid-19 vaccine, which is still given under an emergency use authorization or EUA.

Comments closed

How Trump 2.0 is slashing NIH-backed research — in charts

The US National Institutes of Health (NIH) has terminated nearly 800 research projects at a breakneck pace, wiping out significant chunks of funding to entire scientific fields, finds a Nature analysis of the unprecedented cuts.

The administration of US President Donald Trump began purging NIH-funded studies on topics that it deems problematic less than 50 days ago, continuously expanding its list to include research on topics ranging from COVID-19 to misinformation. Hundreds of the 30,000-plus scientists funded by the NIH yearly have been forced to halt their work after receiving notices that their research “no longer effectuates agency priorities”, and some have had to fire personnel or even shut down their laboratories.

Comments closed

Studies: 1 in 7 US working-age adults report long COVID, with heaviest burden on the poor

Nearly 1 in 7 working-age US adults had experienced long COVID by late 2023, and socially disadvantaged adults were over 150% more likely to have persistent symptoms, two new studies find.

Future public health, economic burdens

Yesterday in Communications Medicine, Daniel Kim, MD, DrPH, of Northeastern University, analyzed data from the US Census Bureau’s Household Pulse Survey from September and November 2022 and August to October 2023 on more than 375,000 US adults, including nearly 50,000 with self-reported long COVID.

Kim assessed sociodemographic and socioeconomic factors as predictors of long COVID; estimated the risk of unemployment, financial difficulties, and anxiety and depression among working-age adults (ages 18 to 64 years) and those currently experiencing lingering symptoms; and tallied the economic effects of the resulting lost wages.

Comments closed

Top scientists pen letter calling for end to ‘assault on U.S. science’

Nearly 2,000 doctors, researchers, and scientists have signed an open letter calling for an end to what they describe as the Trump administration’s “wholesale assault on U.S. science.”

The letter, written by 13 scientists from disciplines including medicine, climate science and economics, urges Americans to demand their Congress protect scientific funding and integrity.

The signatories, all members of the National Academies of Sciences, Engineering, and Medicine, wrote that the Trump administration is “destabilizing this enterprise by gutting funding for research, firing thousands of scientists, removing public access to scientific data, and pressuring researchers to alter or abandon their work on ideological grounds.”

Comments closed

Rollout of ‘miracle’ HIV prevention drug is threatened by Trump cuts to global AIDS relief program

The Trump administration’s enormous cuts to a global AIDS relief program threaten to upend the planned rollout of a groundbreaking HIV prevention drug that was expected to save countless lives.

The medicine, lenacapavir, made by Gilead Sciences, has caused a stir because clinical trial data showed a single set of injections every six months could provide virtually complete protection against infection, a form of prevention known as pre-exposure prophylaxis, or (PrEP). The drug, which is under regulatory review, has raised hopes that the deadly infectious disease can be mitigated around the globe. Early data for an even newer formulation suggest it might need to be given only once a year. “This is magical,” UNAIDS chief Winnie Byanyima declared last year.

Comments closed

Trump’s proposed tariffs likely to cause shortages of Canadian-made drugs in U.S., study says

U.S. President Donald Trump’s proposed tariffs on pharmaceuticals are likely to cause shortages of dozens of Canadian-made drugs in the United States, according to a new study.

Pharmaceuticals are one of a handful of sector-specific tariffs the President has talked publicly about imposing, along with ones already levied on steel, aluminum and autos. Mr. Trump has suggested tariffs could address high drug costs in the U.S. and increase domestic manufacturing.

New research published Monday in the Journal of the American Medical Association looked at how many and what kind of Canadian-made drugs would be hit by the tariffs. It found US$3-billion in annual sales came from drugs with final production in Canada, which would lead to an increased cost of US$750-million for American buyers if tariffs were set at 25 per cent. Of the Canadian-made drugs, 79 per cent were generics.

Comments closed

US cutting Gavi vaccine alliance aid may cause ‘over a million deaths’

Paris (AFP) – The United States cutting funding to Gavi, an organisation that provides vaccines to the world’s poorest countries, could result in more than a million deaths and will endanger lives everywhere, the group’s CEO warned on Thursday.

The news that Washington is planning to end funding for Gavi, first reported in the New York Times, comes as the two-month-old administration of President Donald Trump aggressively slashes foreign aid.

Comments closed

‘Something was wrong with my brain’: How covid leaves its mark on cognition

In March 2020, Hannah Davis fell ill, and everything changed. Her respiratory symptoms were mild, but the neurological and cognitive fallout was frightening.

“I could tell very early on that something was wrong with my brain,” she said after getting sick with covid-19.

And Davis had quantitative proof — her score for processing speed on a cognitive test dropped from the 96th percentile right before the pandemic to the 14th percentile after her coronavirus infection.

Comments closed

CDC is pulling back $11B in Covid funding sent to health departments across the U.S.

The Centers for Disease Control and Prevention is pulling back $11.4 billion in funds allocated in response to the pandemic to state and community health departments, nongovernment organizations and international recipients, the Department of Health and Human Services confirmed Tuesday.

“The COVID-19 pandemic is over, and HHS will no longer waste billions of taxpayer dollars responding to a non-existent pandemic that Americans moved on from years ago,” HHS Director of Communications Andrew Nixon said in a statement. “HHS is prioritizing funding projects that will deliver on President Trump’s mandate to address our chronic disease epidemic and Make America Healthy Again.”

HHS oversees 13 agencies, including the CDC, which is tasked with protecting the nation’s health. Notices began going out Monday, and awardees have 30 days to reconcile their expenditures. Figures are subject to change.

Comments closed

I traded my U.S. medical career for life in Canada. Here’s how the two health systems stack up.

After more than a decade practicing emergency medicine in the United States, I very recently began working shifts in Canada. The differences hit me immediately, and are profound.

What follows are a series of working hypotheses — early impressions shaped by firsthand experience and years of health policy work in the U.S. I expect they will evolve with time, but they already point to important contrasts in how both countries approach medicine, physician autonomy, and the doctor-patient relationship.

Comments closed

Long Covid office ‘will be closing,’ Trump administration announces

The Trump administration is shuttering HHS’ long Covid office as part of its reorganization, according to an internal email seen by POLITICO.

The email was sent Monday by Ian Simon, the head of the Office of Long Covid Research and Practice. It said the closing is part of the Department of Health and Human Services’ reorganization.

Comments closed

UN warns millions more will die from AIDS after US cuts

The UNAIDS program head has said millions more will die as a result of the sudden cuts to funding by the Trump administration. She also warned that the AIDS pandemic could return to 1990s levels.

The head of the United Nations program on HIV/AIDS, UNAIDS, said on Monday that over 6 million additional deaths from the disease are expected after the US slashed its funding.

Comments closed

Beyond long COVID — how reinfections could be causing silent long-term organ damage

COVID may no longer be considered an official global emergency, but mounting scientific evidence suggests every COVID infection a person gets increases their risk of developing long-term health issues.

“There is no such thing as a COVID infection without consequence,” says long COVID researcher, David Putrino, from the Icahn School of Medicine at Mount Sinai in New York.

The long-term effects can show up as long COVID, with symptoms such as shortness of breath, digestive problems, fast or irregular heartbeats, extreme fatigue and brain fog, or as silently accumulating cellular or organ damage.

Comments closed

Trump’s EPA aims to cut pollution rules projected to save nearly 200,000 lives: ‘People will be hurt’

A push by Donald Trump’s administration to repeal a barrage of clean air and water regulations may deal a severe blow to US public health, with a Guardian analysis finding that the targeted rules were set to save the lives of nearly 200,000 people in the years ahead.

Last week, Trump’s Environmental Protection Agency (EPA) provoked uproar by unveiling a list of 31 regulations it will scale back or eliminate, including rules limiting harmful air pollution from cars and power plants; restrictions on the emission of mercury, a neurotoxin; and clean water protections for rivers and streams.

Comments closed